Future of Healthcare Investment Forum

  • 12:00, 19 Jun 24 - 17:50, 19 Jun 24
  • 10 Paternoster Square, London
  • Print page

The London Stock Exchange together with sponsors A&O Shearman, Deutsche Numis, FTI Consulting and J.P. Morgan, and supported by The BioIndustry Association and Department for Business and Trade, have pleasure in inviting you to the 9th annual Future of Healthcare Investment Forum on Wednesday, 19 June 2024.

We are pleased to announce that our two keynote speakers and panellists will include:

Keynote Speakers:

  • Sir Nigel Wilson, Co-author, Capital Markets of Tomorrow report; formerly Group Chief  Executive, Legal & General Group plc
  • Prof. Nadeem Sarwar, Co-Founder and Head of the Transformational Prevention Unit, Novo Nordisk; Co-Chair, UK Dementia Mission; and Honorary Professor at the University of Edinburgh

Panel 1: Financing healthcare - UK, US, private and public

  • Richard Bungay, CEO, Imophoron
  • Bernie Cooney, Senior Partner, Flagship Pioneering  
  • Mark Hankinson, Co-Head of ECM, Deutsche Numis
  • Greg Smith, CEO, IP Group plc
  • Clare Terlouw, Head of LifeArc Ventures
  • Moderator: Ashleigh Furlong, Health Reporter, Bloomberg

Panel 2: Neurodegeneration and neuropsychology

  • Jenny Barnett, CEO, Monument Therapeutics 
  • Olivia Cavlan, Chief Corporate Development and Strategy Officer, Alchemab Therapeutics
  • Lisa Deschamps, CSO, AviadoBio
  • Dr Ruth McKernan, Founder, AstronauTx; Venture Partner, Dementia Discovery Fund
  • Robin Wolz, CSO, IXICO plc
  • Moderator: Kevin Grogan, Managing Editor Europe, Scrip

Panel 3: Metabolic diseases - the UK's biggest unmet need?

  • Ilan Chaitowitz, CEO, BioZen
  • Frédéric Cren, CEO, Inventiva 
  • Alejandro Galindo, CEO, Quanta Dialysis Technologies
  • John Tsai, Board Director, Purespring Therapeutics; Executive Partner, Syncona
  • Moderator: Stephen Hansen, Director of Biopharma Intelligence, BioCentury